XML 24 R7.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statements of Changes in Shareholders' Equity - USD ($)
$ in Thousands
Total
Adjustment
Common Stock
Retained Earnings
Retained Earnings
Adjustment
Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2022 [1]     17,067,253      
Beginning balance at Dec. 31, 2022 $ 112,463 [1] $ (4,678) $ 60,030 [1] $ 69,928 [1] $ (4,678) $ (17,495) [1]
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Other comprehensive income 2,457         2,457
Dividends on common stock (5,992)     (5,992)    
Dividends payable (2,059)     (2,059)    
Restricted stock units released (in shares)     57,185      
RSU tax withholdings $ (29)   $ (29)      
Restricted stock award granted (in shares)     14,435      
Stock option exercised (in shares) 29,022   29,022      
Stock options exercised $ 106   $ 106      
Stock-based compensation expense 478   $ 478      
Net Income $ 19,796     19,796    
Ending balance (in shares) at Dec. 31, 2023 17,167,895   17,167,895 [2]      
Ending balance at Dec. 31, 2023 [2] $ 122,542   $ 60,585 76,995   (15,038)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Other comprehensive income 686         686
Dividends on common stock (6,248)     (6,248)    
Dividends payable (2,083)     (2,083)    
Restricted stock units released (in shares)     28,710      
RSU tax withholdings $ (10)   $ (10)      
Restricted stock award granted (in shares)     168,289      
Stock option exercised (in shares) 0          
Stock-based compensation expense $ 692   $ 692      
Net Income $ 14,783     14,783    
Ending balance (in shares) at Dec. 31, 2024 17,364,894   17,364,894 [3]      
Ending balance at Dec. 31, 2024 [3] $ 130,362   $ 61,267 $ 83,447   $ (14,352)
[1]
(1) Excludes 13,974 unvested restricted shares
[2]
(2) Excludes 21,435 unvested restricted shares
[3]
(3) Excludes 160,991 unvested restricted shares